Welcome to the InfoSci Platform
Reference Hub11
Applications of Chemoinformatics in Predictive Toxicology for Regulatory Purposes, Especially in the Context of the EU REACH Legislation

Applications of Chemoinformatics in Predictive Toxicology for Regulatory Purposes, Especially in the Context of the EU REACH Legislation

Rafael Gozalbes, Jesús Vicente de Julián-Ortiz
Copyright: © 2018 |Volume: 3 |Issue: 1 |Pages: 24
ISSN: 2379-7487|EISSN: 2379-7479|EISBN13: 9781522547235|DOI: 10.4018/IJQSPR.2018010101
Cite Article Cite Article

MLA

Gozalbes, Rafael, and Jesús Vicente de Julián-Ortiz. "Applications of Chemoinformatics in Predictive Toxicology for Regulatory Purposes, Especially in the Context of the EU REACH Legislation." IJQSPR vol.3, no.1 2018: pp.1-24. http://doi.org/10.4018/IJQSPR.2018010101

APA

Gozalbes, R. & Vicente de Julián-Ortiz, J. (2018). Applications of Chemoinformatics in Predictive Toxicology for Regulatory Purposes, Especially in the Context of the EU REACH Legislation. International Journal of Quantitative Structure-Property Relationships (IJQSPR), 3(1), 1-24. http://doi.org/10.4018/IJQSPR.2018010101

Chicago

Gozalbes, Rafael, and Jesús Vicente de Julián-Ortiz. "Applications of Chemoinformatics in Predictive Toxicology for Regulatory Purposes, Especially in the Context of the EU REACH Legislation," International Journal of Quantitative Structure-Property Relationships (IJQSPR) 3, no.1: 1-24. http://doi.org/10.4018/IJQSPR.2018010101

Export Reference

Mendeley
Favorite Full-Issue Download

Abstract

Chemoinformatics methodologies such as QSAR/QSPR have been used for decades in drug discovery projects, especially for the finding of new compounds with therapeutic properties and the optimization of ADME properties on chemical series. The application of computational techniques in predictive toxicology is much more recent, and they are experiencing an increasingly interest because of the new legal requirements imposed by national and international regulations. In the pharmaceutical field, the US Food and Drug Administration (FDA) support the use of predictive models for regulatory decision-making when assessing the genotoxic and carcinogenic potential of drug impurities. In Europe, the REACH legislation promotes the use of QSAR in order to reduce the huge amount of animal testing needed to demonstrate the safety of new chemical entities subjected to registration, provided they meet specific conditions to ensure their quality and predictive power. In this review, the authors summarize the state of art of in silico methods for regulatory purposes, with especial emphasis on QSAR models.

Request Access

You do not own this content. Please login to recommend this title to your institution's librarian or purchase it from the IGI Global bookstore.